BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29636421)

  • 1. Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing.
    Dong Q; Li X; Wang CZ; Xu S; Yuan G; Shao W; Liu B; Zheng Y; Wang H; Lei X; Zhang Z; Zhu B
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4013-E4022. PubMed ID: 29636421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
    Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
    Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
    Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
    J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of STAT1-Driven Transcriptional Activity by Histone Deacetylases.
    Owusu BY; Klampfer L
    Methods Mol Biol; 2017; 1510():277-285. PubMed ID: 27761828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2.
    Icardi L; Lievens S; Mori R; Piessevaux J; De Cauwer L; De Bosscher K; Tavernier J
    FASEB J; 2012 Jan; 26(1):240-9. PubMed ID: 21957129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holocarboxylase synthetase acts as a biotin-independent transcriptional repressor interacting with HDAC1, HDAC2 and HDAC7.
    Trujillo-Gonzalez I; Cervantes-Roldan R; Gonzalez-Noriega A; Michalak C; Reyes-Carmona S; Barrios-Garcia T; Meneses-Morales I; Leon-Del-Rio A
    Mol Genet Metab; 2014 Mar; 111(3):321-330. PubMed ID: 24239178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of the interactions between endosomal adaptor protein APPL1 and the NuRD co-repressor complex.
    Banach-Orlowska M; Pilecka I; Torun A; Pyrzynska B; Miaczynska M
    Biochem J; 2009 Oct; 423(3):389-400. PubMed ID: 19686092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
    Tanaka T; Ohkubo S; Tatsuno I; Prives C
    Cell; 2007 Aug; 130(4):638-50. PubMed ID: 17719542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential roles of HDAC1 and 2 in lineage development and genome-wide DNA methylation during mouse preimplantation development.
    Zhao P; Wang H; Wang H; Dang Y; Luo L; Li S; Shi Y; Wang L; Wang S; Mager J; Zhang K
    Epigenetics; 2020 Apr; 15(4):369-385. PubMed ID: 31533525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
    Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
    Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
    Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
    Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
    Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
    Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AtMBD6, a methyl CpG binding domain protein, maintains gene silencing in Arabidopsis by interacting with RNA binding proteins.
    Parida AP; Sharma A; Sharma AK
    J Biosci; 2017 Mar; 42(1):57-68. PubMed ID: 28229965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1.
    Taplick J; Kurtev V; Kroboth K; Posch M; Lechner T; Seiser C
    J Mol Biol; 2001 Apr; 308(1):27-38. PubMed ID: 11302704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell gene SALL4 suppresses transcription through recruitment of DNA methyltransferases.
    Yang J; Corsello TR; Ma Y
    J Biol Chem; 2012 Jan; 287(3):1996-2005. PubMed ID: 22128185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nucleoporin Nup358/RanBP2 promotes nuclear import in a cargo- and transport receptor-specific manner.
    Wälde S; Thakar K; Hutten S; Spillner C; Nath A; Rothbauer U; Wiemann S; Kehlenbach RH
    Traffic; 2012 Feb; 13(2):218-33. PubMed ID: 21995724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.